Abstract

Currently, malignant neoplasms are one of the leading causes of mortality not only in the world, but also in the Kyrgyz Republic. By 2030, the number of new cancer cases is projected to increase to 26.4 million per year and the number of deaths to 17 million. In assessing cancer incidence and mortality from 25 major cancers in 40 countries in Europe, breast cancer was one of the most common causes of cancer death. Statistical data from the Electronic Health Centre and the National Oncology and Hematology Centre of the Ministry of Health of the Kyrgyz Republic were analyzed. In the Kyrgyz Republic, there is a positive trend among women in the increase in the incidence of malignant neoplasms in 0.03% in 2016 to 1.7% in 2015 and 2018. By the regions of the Republic, a high level of morbidity was revealed with an increase in the indicator in Batken, Issyk–Kul, Osh region and Osh city. The prevalence of malignant new growths of a mammary gland among women of the Kyrgyz Republic tended growth in the studied years for 1.5, 2.1, 1.7 and 1.9% respectively. Across the regions of the republic in all years the growth of the indicator was observed in Jalal–Abad, Issyk–Kul, Osh regions and Osh. There was also an increase in the Batken and Naryn regions, except in 2015. In 2018, compared to 2014, there was a decrease in female mortality from malignant neoplasms by 61.8% in terms of visibility. In terms of mortality from malignant breast neoplasms, there is a reverse trend among women of the Republic. Thus, the indicator increased by 107.6%. The main reasons for the high one-year fatality are the late appeal of patients to specialists, the lack of qualified personnel at the primary level of medical services, the absence of observation rooms in family medicine centers, the reduction of oncological caution of doctors and the population of the Republic. Screening of the female population and treatment of pre-tumor breast diseases should be carried out.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call